substance p has been researched along with Huntington Disease in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (48.08) | 18.7374 |
1990's | 13 (25.00) | 18.2507 |
2000's | 11 (21.15) | 29.6817 |
2010's | 2 (3.85) | 24.3611 |
2020's | 1 (1.92) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Chen, L; Chen, XY; Xue, Y | 1 |
Gasparini, F; Gomez-Mancilla, B; Gulya, K; Gulyás, B; Halldin, C; Jia, Z; Maguire, RP; Schumacher, M; Sovago, J; Szigeti, C | 1 |
Allen, KL; Faull, RL; Glass, M; Waldvogel, HJ | 1 |
Bianco, MR; Cirillo, G; Maggio, N; Papa, M; Sellitti, S; Vollono, C | 1 |
Ariano, MA; Aronin, N; Difiglia, M; Hayden, MR; Leavitt, BR; Levine, MS; Sibley, DR; Tagle, DA | 1 |
Kanazawa, I | 1 |
Del Mar, N; Goldowitz, D; Meade, C; Reiner, A; Sun, Z | 1 |
Reiner, A | 1 |
Albin, RL; Anderson, KD; Deng, YP; Penney, JB; Reiner, A; Young, AB | 1 |
Benraiss, A; Chmielnicki, E; Cho, SR; Economides, A; Goldman, SA; Samdani, A | 1 |
Arregui, A; Clement-Jones, V; Emson, PC; Rossor, M; Sandberg, BE | 1 |
Brown, MR; Buck, SH; Burks, TF; Yamamura, HI | 1 |
Cramer, H; Kohler, J; Oepen, G; Schomburg, G; Schröter, E | 1 |
Bouras, C; Constantinidis, J; Richard, J | 1 |
Vacca, LL | 1 |
Aronin, N; Bird, ED; Cooper, PE; Leeman, SE; Lorenz, LJ; Martin, JB; Sagar, SM | 1 |
Landis, DM; Marshall, PE; Zalneraitis, EL | 1 |
Beal, MF; Landis, DM; Marshall, PE; Martin, JB; Sagar, SM | 1 |
Aizawa, H; Bird, E; DiFiglia, M; Ge, P; Penney, J; Sapp, E; Vonsattel, JP; Young, AB | 1 |
Ferrante, RJ; Kosofsky, BE; Kowall, NW; Krause, JE; Lu, F; Quigley, BJ | 1 |
Beal, MF; Storey, E | 1 |
Augood, SJ; Emson, PC; Faull, RL; Love, DR | 1 |
Chen, Q; Reiner, A | 1 |
Cicchetti, F; Hayden, MR; Nasir, J; O'Kusky, JR; Parent, A | 1 |
Bordelon, YM; Chesselet, MF | 1 |
Brickell, KL; Faull, RL; Nicholson, LF; Waldvogel, HJ | 1 |
De Waal, RM; Kremer, HP; Ten Donkelaar, HJ; Verbeek, MM; Vis, JC | 1 |
Carpenter, E; Chesselet, MF; Koppel, A; MacKenzie, L; Menalled, L; Zanjani, H; Zeitlin, S | 1 |
Figueredo-Cardenas, G; Fusco, F; Meade, CA; Nowak, TS; Pulsinelli, WA; Reiner, A | 1 |
Barami, K; Hutchins, KD; Lyman, WD | 1 |
Deng, YP; MacDonald, ME; Reiner, A; Richfield, EK; Sun, Z; Vonsattel, JP | 1 |
Bird, E; Kanazawa, I; O'Connell, R; Powell, D | 1 |
Yoshida, M | 1 |
Bird, ED; Gale, JS; Ivejsen, LL; Jessel, T; Spoke, EG | 1 |
Beal, MF; Finn, SF; Kowall, NW; Mazurek, MF; Storey, E | 1 |
Albin, RL; Anderson, KD; Balfour, R; Dure, LS; Handelin, B; Penney, JB; Reiner, A; Whetsell, WO; Young, AB | 1 |
Albin, RL; Anderson, KD; Balfour, R; Handelin, B; Markel, DS; Penney, JB; Reiner, A; Tourtellotte, WW; Young, AB | 1 |
Beal, MF; Ferrante, RJ; Kowall, NW; Swartz, KJ | 1 |
Bogerts, B; Zech, M | 1 |
Tan, MX | 1 |
Vacca-Galloway, LL | 1 |
Dawbarn, D; Dockray, G; Emson, P; Mountjoy, C; Rossor, M; Roth, M | 1 |
Bird, ED; Ferrante, RJ; Kowall, NW; Martin, JB; Richardson, EP | 1 |
Klawans, HL | 1 |
Arai, H; Carrasco, LH; Emson, PC | 1 |
Beal, MF; Bird, ED; Ellison, DW; Malloy, JR; Martin, JB; Mazurek, MF; Swartz, KJ | 1 |
Hunt, SP; Peck, R; Reynolds, GP; Rossor, M; Waters, CM | 1 |
Albin, RL; Anderson, KD; D'Amato, CJ; Penney, JB; Reiner, A; Young, AB | 1 |
Beal, MF; Bird, ED; Finn, SF; Martin, JB; Swartz, KJ | 1 |
Beal, MF; Ferrante, RJ; Kowall, NW; Martin, JB; Swartz, KJ | 1 |
Goto, S; Hirano, A; Rojas-Corona, RR | 1 |
Eng, LF; Forno, LS; Grafe, MR | 1 |
7 review(s) available for substance p and Huntington Disease
Article | Year |
---|---|
The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities.
Topics: Animals; Endocannabinoids; Enkephalins; Globus Pallidus; Humans; Huntington Disease; Neuropeptides; Parkinson Disease; Substance P | 2020 |
Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
Topics: Alzheimer Disease; Brain Mapping; Central Nervous System Diseases; Cholecystokinin; Enkephalins; Humans; Huntington Disease; Limbic System; Nerve Tissue Proteins; Neurotransmitter Agents; Parkinson Disease; Schizophrenia; Substance P; Substance-Related Disorders | 1983 |
Implications of neuropeptides in neurological diseases.
Topics: Alzheimer Disease; Animals; Brain; Cholecystokinin; Choline O-Acetyltransferase; Endorphins; Epilepsy; Forecasting; Histocytochemistry; Humans; Huntington Disease; Migraine Disorders; Nerve Tissue Proteins; Nervous System Diseases; Pain; Parkinson Disease; Radioimmunoassay; Somatostatin; Substance P; Thyrotropin-Releasing Hormone; Tissue Distribution; Vasopressins | 1984 |
Substance P and substance P receptor histochemistry in human neurodegenerative diseases.
Topics: Brain; Brain Chemistry; Corpus Striatum; Humans; Huntington Disease; Immunohistochemistry; Neurons; Receptors, Neurokinin-1; Substance P | 1993 |
[Peptide neurotransmitters and extrapyramidal disorders].
Topics: Animals; Basal Ganglia Diseases; Enkephalins; Humans; Huntington Disease; MSH Release-Inhibiting Hormone; Parkinson Disease; Substance P | 1985 |
Postmortem studies of peptides in Alzheimer's disease and Huntington's disease.
Topics: Alzheimer Disease; Basal Ganglia; Brain; Brain Chemistry; Cerebral Cortex; Choline O-Acetyltransferase; Enkephalin, Methionine; FMRFamide; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Huntington Disease; Nerve Tissue Proteins; Neurofibrils; Neuropeptide Y; Neurotensin; Oligopeptides; Peptides; Substance P; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide | 1986 |
Chorea.
Topics: Antipsychotic Agents; Cholinergic Fibers; Chorea; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Reserpine; Serotonin; Somatostatin; Substance P | 1987 |
45 other study(ies) available for substance p and Huntington Disease
Article | Year |
---|---|
Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain.
Topics: Aged; Autopsy; Brain; Enkephalins; Female; Humans; Huntington Disease; Male; Middle Aged; Positron-Emission Tomography; Receptor, Metabotropic Glutamate 5; Substance P | 2015 |
Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Topics: Aged; Aged, 80 and over; Brain Mapping; Cannabinoid Receptor Modulators; Down-Regulation; Enkephalins; Female; gamma-Aminobutyric Acid; Globus Pallidus; Humans; Huntington Disease; Immunohistochemistry; Male; Microscopy, Confocal; Middle Aged; Nerve Degeneration; Neuronal Plasticity; Neurons; Receptor, Cannabinoid, CB1; Receptors, GABA-A; Receptors, GABA-B; Substance P; Up-Regulation | 2009 |
Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.
Topics: Animals; Astrocytes; Basal Ganglia; Basal Ganglia Diseases; Behavior, Animal; Disability Evaluation; Disease Models, Animal; Excitatory Amino Acid Transporter 1; Glial Fibrillary Acidic Protein; Gliosis; Huntington Disease; Male; Movement Disorders; Neurons; Neuropsychological Tests; Neurotoxins; Nitro Compounds; Propionates; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Substance P; Synaptic Transmission; Time Factors | 2010 |
Striatal neurochemical changes in transgenic models of Huntington's disease.
Topics: Animals; Corpus Striatum; Cyclic AMP; Down-Regulation; Enkephalin, Methionine; Fluorescent Antibody Technique; Huntington Disease; Mice; Mice, Transgenic; Phosphorylation; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D5; Signal Transduction; Substance P; Tyrosine 3-Monooxygenase; Up-Regulation | 2002 |
[On what I learned from researches on Huntington's disease].
Topics: Animals; Corpus Striatum; gamma-Aminobutyric Acid; Humans; Huntington Disease; Inclusion Bodies; Neurotransmitter Agents; Rats; Substance P; Substantia Nigra; Trinucleotide Repeat Expansion | 2001 |
Differential changes in striatal projection neurons in R6/2 transgenic mice for Huntington's disease.
Topics: Age Factors; Animals; Autoradiography; Corpus Striatum; Disease Models, Animal; Enkephalins; Gene Expression; Genotype; Globus Pallidus; Huntington Disease; Immunohistochemistry; In Situ Hybridization; Mice; Mice, Transgenic; Neural Pathways; Neurons; Nucleus Accumbens; Protein Precursors; RNA, Messenger; Substance P; Substantia Nigra; Tachykinins | 2002 |
Can lesions of GPe correct HD deficits?
Topics: Animals; Disease Models, Animal; Enkephalins; gamma-Aminobutyric Acid; Globus Pallidus; Humans; Huntington Disease; Substance P | 2004 |
Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Corpus Striatum; Female; Glutamate Decarboxylase; Humans; Huntington Disease; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Middle Aged; Neural Pathways; Neurons; Substance P | 2004 |
Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease.
Topics: Adenoviridae; Animals; Brain-Derived Neurotrophic Factor; Carrier Proteins; Disease Models, Animal; Disease Progression; Enkephalins; Globus Pallidus; Huntington Disease; Mice; Mice, Transgenic; Mitosis; Neostriatum; Neurons; Regeneration; Substance P; Tubulin | 2007 |
Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Endorphins; Enkephalins; Humans; Huntington Disease; Mice; Middle Aged; Radioimmunoassay; Substance P | 1980 |
Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.
Topics: Aged; Basal Ganglia; Brain; Humans; Huntington Disease; Middle Aged; Neurons; Substance P; Substantia Nigra | 1981 |
Huntington's chorea-- measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid.
Topics: Adult; Aged; Brain; Cyclic AMP; Cyclic GMP; Female; Humans; Huntington Disease; Male; Middle Aged; Somatostatin; Substance P | 1981 |
Substance P appears reduced in Huntington's disease: immunocytochemical findings in substantia nigra and substantia gelatinosa.
Topics: Aged; Female; Humans; Huntington Disease; Immunologic Techniques; Male; Middle Aged; Neural Pathways; Spinal Cord; Substance P; Substantia Gelatinosa; Substantia Nigra | 1983 |
Somatostatin is increased in the basal ganglia in Huntington disease.
Topics: Adolescent; Adult; Aged; Basal Ganglia; Caudate Nucleus; Child; Chromatography, Gel; Chromatography, High Pressure Liquid; Female; Globus Pallidus; Humans; Huntington Disease; Male; Middle Aged; Putamen; Radioimmunoassay; Somatostatin; Substance P | 1983 |
Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
Topics: Adolescent; Adult; Aged; Brain; Caudate Nucleus; Corpus Striatum; Enkephalin, Leucine; Globus Pallidus; Humans; Huntington Disease; Immunoenzyme Techniques; Middle Aged; Nerve Degeneration; Neural Pathways; Neurons; Putamen; Substance P; Substantia Nigra | 1983 |
Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.
Topics: Aged; Enkephalins; Globus Pallidus; Humans; Huntington Disease; Image Processing, Computer-Assisted; Immunochemistry; Microscopy; Middle Aged; Substance P | 1995 |
Neurochemical substrates of rigidity and chorea in Huntington's disease.
Topics: Adolescent; Adult; Aged; Basal Ganglia; Child; Enkephalin, Methionine; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Huntington Disease; Male; Middle Aged; Models, Biological; Muscle Rigidity; Substance P; Thalamus | 1993 |
Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study.
Topics: Aged; Aged, 80 and over; Enkephalins; Female; Gene Expression; Humans; Huntington Disease; Image Processing, Computer-Assisted; In Situ Hybridization; Male; Middle Aged; Neostriatum; RNA, Messenger; Substance P | 1996 |
Cellular distribution of the NMDA receptor NR2A/2B subunits in the rat striatum.
Topics: Acetylcholine; Animals; Calbindins; Corpus Striatum; Enkephalins; Huntington Disease; Interneurons; Male; Nerve Tissue Proteins; Neurons; Parvalbumins; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; S100 Calcium Binding Protein G; Somatostatin; Substance P | 1996 |
Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene.
Topics: Afferent Pathways; Animals; Basal Ganglia; Enkephalins; Gene Targeting; Globus Pallidus; Heterozygote; Huntington Disease; Immunohistochemistry; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroglia; Neurons; Substance P; Synapses; Thalamic Nuclei | 1999 |
Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.
Topics: Animals; Basal Ganglia; Corpus Striatum; Cytoskeleton; Disease Models, Animal; DNA Damage; Efferent Pathways; Enkephalins; Excitatory Amino Acid Agonists; Globus Pallidus; Huntington Disease; Injections; Male; Mice; Mice, Neurologic Mutants; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neurons; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Substance P | 1999 |
Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes.
Topics: Animals; Autoradiography; Corpus Striatum; Disease Models, Animal; Huntington Disease; Immunohistochemistry; Male; Neuroglia; Nissl Bodies; Quinolinic Acid; Rats; Rats, Wistar; Receptors, GABA-A; Substance P; Substantia Nigra; Time Factors | 1999 |
3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
Topics: Animals; Corpus Striatum; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Hindlimb; Huntington Disease; Immunohistochemistry; Male; Motor Activity; Neurons; Neurotoxins; Nitro Compounds; Propionates; Rats; Rats, Wistar; Somatostatin; Substance P | 1999 |
Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease.
Topics: Animals; Biomarkers; Calbindins; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; DNA Damage; Enkephalins; Female; Glutamate Decarboxylase; Homozygote; Huntingtin Protein; Huntington Disease; Isoenzymes; Male; Mice; Mice, Knockout; Mice, Neurologic Mutants; Motor Activity; Nerve Tissue Proteins; Neurons; Nuclear Proteins; RNA, Messenger; S100 Calcium Binding Protein G; Substance P; Trinucleotide Repeats | 2000 |
Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease.
Topics: Animals; Cell Survival; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, Animal; Enkephalins; Huntington Disease; Image Processing, Computer-Assisted; Interneurons; Ischemic Attack, Transient; Male; NADPH Dehydrogenase; Nerve Fibers; Neural Pathways; Rats; Rats, Sprague-Dawley; Rats, Wistar; Somatostatin; Substance P | 2000 |
Neurotransmitter distribution in the second trimester fetal human corpus striatum.
Topics: Acetylcholine; Age Factors; Brain Tissue Transplantation; Corpus Striatum; Enkephalins; Female; Fetal Tissue Transplantation; Fetus; gamma-Aminobutyric Acid; Humans; Huntington Disease; Neurons; Neuropeptide Y; Neurotransmitter Agents; Pregnancy; Pregnancy Trimester, Second; Substance P | 2001 |
Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease.
Topics: Aged; Cell Survival; Corpus Striatum; Enkephalins; Female; Gene Expression; Globus Pallidus; Humans; Huntington Disease; Neurologic Examination; Neurons; Phenotype; Polymerase Chain Reaction; Protein Precursors; Substance P; Tachykinins; Trinucleotide Repeats | 2002 |
Evidence for a decrease in substance P content of substantia nigra in Huntington's chorea.
Topics: Adult; Aged; Female; Glutamate Decarboxylase; Humans; Huntington Disease; Male; Middle Aged; Substance P; Substantia Nigra; Tyrosine 3-Monooxygenase | 1977 |
[Basal ganglia lesions and neurotransmitters].
Topics: Acetylcholine; Animals; Basal Ganglia; Dopamine; gamma-Aminobutyric Acid; Humans; Huntington Disease; Neurotransmitter Agents; Parkinson Disease; Rabbits; Rats; Substance P; Substantia Nigra | 1978 |
Human brain substance P: distribution in controls and Huntington's chorea.
Topics: Brain; Humans; Huntington Disease; Reference Values; Substance P; Tissue Distribution | 1978 |
The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex.
Topics: Age Factors; Aged; Animals; Aspartic Acid; Brain Chemistry; Cholecystokinin; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glutamine; Humans; Huntington Disease; Male; Middle Aged; N-Methylaspartate; Neurochemistry; Rats; Rats, Sprague-Dawley; Somatostatin; Substance P | 1992 |
Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
Topics: Adult; Cell Survival; Corpus Striatum; Enkephalins; Glial Fibrillary Acidic Protein; Globus Pallidus; Humans; Huntington Disease; Immunohistochemistry; Male; Neurons; Substance P; Synaptic Transmission | 1992 |
Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease.
Topics: Adult; Aspartic Acid; Corpus Striatum; Female; Heterozygote; Humans; Huntington Disease; Immunohistochemistry; N-Methylaspartate; Neurons; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Substance P; Suicide | 1990 |
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Atrophy; Biogenic Amines; Cerebral Cortex; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamates; Huntington Disease; Ibotenic Acid; Kainic Acid; Male; Mesencephalon; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; Reference Values; Somatostatin; Substance P | 1991 |
Methionine-enkephalin and substance P in the basal ganglia of normals, Parkinson patients, Huntington patients, and schizophrenics. A qualitative immunohistochemical study.
Topics: Adult; Aged; Basal Ganglia; Enkephalin, Methionine; Female; Humans; Huntington Disease; Immunoenzyme Techniques; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Schizophrenia; Substance P | 1985 |
Differential immunostaining for substance P in Huntington's diseased and normal spinal cord: significance of serial (optimal, supra-optimal and end-point) dilutions of primary anti-serum in comparing biological specimens.
Topics: Dose-Response Relationship, Immunologic; Humans; Huntington Disease; Immunoenzyme Techniques; Spinal Cord; Substance P; Substantia Gelatinosa | 1985 |
Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum.
Topics: Acetylcholinesterase; Aged; Corpus Striatum; Enkephalin, Methionine; Female; Histocytochemistry; Humans; Huntington Disease; Immunoenzyme Techniques; Male; Middle Aged; Substance P | 1986 |
Huntington's disease: changes in tachykinin content in postmortem brains.
Topics: Animals; Brain; Humans; Huntington Disease; Immunohistochemistry; Male; Neurokinin A; Neurokinin B; Neuropeptides; Radioimmunoassay; Rats; Rats, Inbred Strains; Substance P; Tachykinins | 1987 |
A detailed examination of substance P in pathologically graded cases of Huntington's disease.
Topics: Aged; Basal Ganglia; Brain; Female; Humans; Huntington Disease; Male; Middle Aged; Substance P | 1988 |
Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
Topics: Adult; Aged; Aged, 80 and over; Basal Ganglia; Catecholamines; Cell Count; Enkephalins; Female; Humans; Huntington Disease; Immunohistochemistry; Male; Middle Aged; Parkinson Disease; Substance P; Substantia Nigra | 1988 |
Differential loss of striatal projection neurons in Huntington disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Axons; Child; Corpus Striatum; Enkephalins; Humans; Huntington Disease; Immunohistochemistry; Middle Aged; Neurons; Substance P | 1988 |
Amino acid and neuropeptide neurotransmitters in Huntington's disease cerebellum.
Topics: Aged; Aspartic Acid; Cerebellum; Female; Humans; Huntington Disease; Male; Middle Aged; Neuropeptide Y; Neuropeptides; Somatostatin; Substance P | 1988 |
Systemic approaches to modifying quinolinic acid striatal lesions in rats.
Topics: 2-Amino-5-phosphonovalerate; Allopurinol; Amino Acids; Animals; Antioxidants; Baclofen; Corpus Striatum; Dibenzocycloheptenes; Disease Models, Animal; Dizocilpine Maleate; Huntington Disease; Ketamine; Male; Neuropeptide Y; Nimodipine; Peptides; Pyridines; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; Substance P; Taurine; Valine | 1988 |
Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders.
Topics: Afferent Pathways; Aged; Brain Diseases; Calcineurin; Calmodulin-Binding Proteins; Corpus Striatum; Enkephalin, Methionine; Female; Globus Pallidus; Humans; Huntington Disease; Immunoenzyme Techniques; Immunohistochemistry; Male; Membrane Proteins; Middle Aged; Phosphoprotein Phosphatases; Substance P; Synaptophysin | 1989 |
Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
Topics: Aged; Alzheimer Disease; Basal Ganglia; Enkephalin, Methionine; Humans; Huntington Disease; Immunochemistry; Middle Aged; Parkinson Disease; Radioimmunoassay; Substance P | 1985 |